United Therapeutics Europe Ltd withdraws its marketing authorisation application for Tyvaso

View source ↗

Summary

United Therapeutics Europe Ltd has withdrawn its marketing authorization application for Tyvaso with the European Medicines Agency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Tyvaso (treprostinil)